Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boston blog main
cancer
3
×
life sciences
national blog main
avapritinib
biotech
blueprint medicines
boston
boston top stories
clinical trials
europe blog main
europe top stories
indiana blog main
indiana top stories
national top stories
san francisco blog main
san francisco top stories
andrew berens
arena pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer drugs
capmatinib
cardiovascular disease
colorectal cancer
deciphera pharmaceuticals
detroit blog main
detroit top stories
eisai
eli lilly
fda
gastrointestinal stromal tumor
gastrointestinal stromal tumors
genentech
gist
gleevec
imatinib
life science
lorcaserin
lung cancer
What
cancer
3
×
drug
fda
3
×
approval
blueprint
medicine
address
announced
approves
carries
certain
chasing
deadly
deciphera
designed
eisai
filing
flags
forms
genetic
gi
higher
incidence
latest
lorcaserin
loss
market
marketing
medicines
morning
pass
patients
pharamceuticals
plans
post
pulls
ret
risks
seek
signature
Language
unset
3
×
Current search:
photo
×
fda
×
cancer
×
cancer
×
unset
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug